Indians are obsessed with cough syrups. Are they really needed?
“Cough syrups are rarely necessary for children under the age of five,” paediatrician and allergy specialist at Sir…
Jacksonville woman says common antibiotic changed her life for worse
JACKSONVILLE, N.C. (WITN) – A Jacksonville resident used to live an active life as a mom and wife.…
FDA upgrades recall for tens of thousands of bottles of commonly prescribed medication
CINCINNATI (WKRC) – The FDA upgraded a recall for a commonly prescribed medication that may pose a health…
What It Means for Access
Shortly before the federal government shut down last week, officials at the Food and Drug Administration quietly approved…
Outside U.S., “Don’t Take Tylenol” Message Sharply Rebuked
Tylenol brand pain reliever (acetaminophen) is under fire by the Trump administration for possible links to autism. Photographer:…
How switching your old lightbulbs for new LED lights increases your risk of diabetes, obesity and even dementia – as experts reveal disturbing link between modern lamps and disease
It sounds almost too good to be true, but researchers think that shining red light at patients could…
Experts warn against new celebrity-led trend for taking common medication to beat anxiety: ‘Raised risk of death’
Experts are warning people against taking the little blue pill celebrities promise will calm nervous jitters in all…
San Antonio clinics use magnetic fields to treat major depression
San Antonio residents who suffer from depression have historically had access to two clinical treatment options: psychotherapy and…
FDA cracks down on prescription drug ads but lacks staff
WASHINGTON – In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health…
Russia claims its cancer vaccine reduces tumors by 80 percent… announces it is safe and ‘ready to use’
Russian government officials have announced what could be a monumental achievement in the fight against colorectal cancer, though details…
Saol Therapeutics hit with CRL for rare genetic disease
The U.S. FDA issued a complete response letter (CRL) for the NDA to privately held Saol Therapeutics Inc.’s…
How a change in FDA guidance might revolutionise MASH drug development
Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) therapy space,…